Skip to main content
padlock icon - secure page this page is secure

Normal expression of myelin protein zero with frame-shift mutation correlates with mild phenotype

Buy Article:

$52.00 + tax (Refund Policy)

Abstract 

Mutations in the gene encoding for myelin protein zero (MPZ) cause inherited demyelinating peripheral neuropathies of different severity. The molecular and cellular mechanisms by which the MPZ mutations cause neuropathy are incompletely understood. We investigated MPZ, myelin basic protein, and peripheral myelin protein 22 (PMP22) protein expression levels in a nerve biopsy of a Charcot-Marie-Tooth type 1B patient heterozygous for the Val 102 frame-shift mutation. We demonstrate by quantitative immunohistochemical as well as by Western blot analyses that MPZ expression levels were not reduced in myelin membranes, a finding that is in accordance with the mild phenotype of this patient. Our data show that heterozygous ‘loss-of-function’ of MPZ may not necessarily lead to reduced protein levels. In conclusion, we demonstrate that careful analysis of protein expression levels in peripheral nerve tissues provides important information with respect to the understanding of the molecular basis of these neuropathies.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: demyelinating disorder; mutation; myelin protein zero; neuropathy

Document Type: Research Article

Affiliations: 1: Departments of Research and Neurology, University Hospital Basel, Pharmacenter, Basel, Switzerland; and 2: Istituto Nazionale Neurologico C. ‘Besta’, Milan, Italy

Publication date: March 1, 2006

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more